Botulinum toxin and human serum albumin.
Malhotra
Raman
R
Huilgol
Shyamala C
SC
Selva
Dinesh
D
D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D004359:Drug Therapy, Combination; D006801:Humans; D007258:Informed Consent; D007880:Legislation, Drug; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D004364:Pharmaceutical Preparations; D017096:Prion Diseases / Q000635:transmission*; D012307:Risk Factors; D012709:Serum Albumin / Q000009:adverse effects / Q000737:chemistry / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D014777:Virus Diseases / Q000635:transmission*
D009465:Neuromuscular Agents; D004364:Pharmaceutical Preparations; D012709:Serum Albumin; D019274:Botulinum Toxins, Type A